Allows terminally ill patients in Hawaii to access investigational drugs or biological products pending FDA approval.

This bill allows terminally ill patients in Hawaii to access investigational drugs or biological products that have not yet been approved by the FDA. It defines "eligible patient" as someone diagnosed with a terminal illness who has considered all other FDA-approved treatment options and cannot participate in a clinical trial within 100 miles of home. The bill also protects health care providers from professional repercussions for recommending such treatments and ensures patients' access to these treatments is not blocked by state officials.

Allows terminally ill patients in Hawaii to access investigational drugs or biological products pending FDA approval.

This bill allows terminally ill patients in Hawaii to access investigational drugs or biological products that have not yet been approved by the FDA. It defines "eligible patient" as someone diagnosed with a terminal illness who has considered all other FDA-approved treatment options and cannot participate in a clinical trial within 100 miles of home. The bill also protects health care providers from professional repercussions for recommending such treatments and ensures patients' access to these treatments is not blocked by state officials.